These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 5337919)

  • 1. Coagulation parameters following extracorporeal circulation using acid-citrate-dextrose blood buffered with tris (hydroxymethyl) aminomethane (THAM).
    Phillips LL; Malm JR
    Transfusion; 1967; 7(3):185-8. PubMed ID: 5337919
    [No Abstract]   [Full Text] [Related]  

  • 2. THE USE OF THAM BUFFERED ACID-DEXTROSE-CITRATE BLOOD FOR EXTRACORPOREAL CIRCULATION.
    MALM JR; BOWMAN FO; SULLIVAN SF; NAHAS GG
    J Cardiovasc Surg (Torino); 1965; 6():134-7. PubMed ID: 14291055
    [No Abstract]   [Full Text] [Related]  

  • 3. Coagulation changes after perfusion with heparinized blood and ACD blood buffered with tris (hydroxy methyl) amino methane.
    Phillips LL; Malm JR
    Bibl Haematol; 1968; 29():858-62. PubMed ID: 5728127
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental investigations into the behaviour of coagulation and renal function during high dilution perfusions with glucose, Haemaccel and Rheomacrodex.
    Trede M
    Bibl Haematol; 1969; 33():553-68. PubMed ID: 5377197
    [No Abstract]   [Full Text] [Related]  

  • 5. SURVIVAL AFTER EXTRACORPOREAL CIRCULATION OF STORED ERYTHROCYTES TREATED WITH ACID-CITRATE-DEXTROSE (ACD) AND HEPARIN.
    KRUMHAAR D; FOOTE AV; MALONEY JV
    J Surg Res; 1963 Oct; 3():404-8. PubMed ID: 14073742
    [No Abstract]   [Full Text] [Related]  

  • 6. ACID-CITRATE-DEXTROSE (ACD) BLOOD IN EXTRACORPOREAL CIRCULATION. AN EXPERIMENTAL STUDY.
    CASTBERG T; SAURBREY J; SIVERTSEN U; WANDALL HH
    Acta Chir Scand; 1964 Dec; 128():671-7. PubMed ID: 14253869
    [No Abstract]   [Full Text] [Related]  

  • 7. CITRATE TOXICITY AND THE USE OF ANTICOAGULANT ACID CITRATE DEXTROSE BLOOD FOR EXTRACORPOREAL CIRCULATION.
    JENNINGS ER; BELAND AJ; COPE JA; ELLESTAD MH; MONROE C; SHADLE OW
    Surg Gynecol Obstet; 1965 May; 120():997-1008. PubMed ID: 14269851
    [No Abstract]   [Full Text] [Related]  

  • 8. Tris (hydroxymethyl) aminomethane (THAM) induced stimulation of insulin release by islets of Langerhans previously isolated from rat pancreas.
    Fedynskyj NM; Beck LV
    Diabetes; 1970 Aug; 19(8):559-62. PubMed ID: 4915446
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of some organic acid salts of tris(hydroxymethyl)aminomethane in the incubation step on plasma renin activity.
    Frazer MG; Pearson DE
    Clin Chim Acta; 1980 Jul; 105(1):117-22. PubMed ID: 6994936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The suitability of tris(hydroxylmethyl) aminomethane (THAM) as a buffering system for hydroxypropyl methylcellulose (HPMC) hydrophilic matrices containing a weak acid drug.
    Pygall SR; Kujawinski S; Timmins P; Melia CD
    Int J Pharm; 2010 Mar; 387(1-2):93-102. PubMed ID: 20005935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On 566 cardiac operations under extracorporeal circulation carried out with blood preserved for 18 to 48 hours in acid citrate dextrose (A.C.D.) solution. (Study of chemical and enzymatic modifications and coagulation disorders)].
    Revol L; Termet H; Vittoz P; Thouverez JP; Mikaeloff P; Counitchansky M
    Bibl Haematol; 1968; 29():739-45. PubMed ID: 5728117
    [No Abstract]   [Full Text] [Related]  

  • 12. [TRANSFUSION PROBLEMS PRESENTED BY EXTRACORPOREAL CIRCULATION. PREPARATION OF THE BLOOD AND CONTROL OF COAGULATION].
    JAULMES B; TERRIER E; SPROVIERI L; CARIGNANI G; PRIGENT C; DUBOST C
    Bibl Haematol; 1964; 19():118-29. PubMed ID: 14266982
    [No Abstract]   [Full Text] [Related]  

  • 13. Tris-hydroxymethyl aminomethane and sodium bicarbonate to buffer metabolic acidosis in an isolated heart model.
    Sirieix D; Delayance S; Paris M; Massonnet-Castel S; Carpentier A; Baron JF
    Am J Respir Crit Care Med; 1997 Mar; 155(3):957-63. PubMed ID: 9117032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of tris(hydroxymethyl) aminomethane (THAM) on kidney circulation in hemorrhagic shock].
    Kirchheim H
    Pflugers Arch Gesamte Physiol Menschen Tiere; 1965 Nov; 286(4):323-35. PubMed ID: 5222713
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of heparin and of acid-citrate-dextrose solution on screen filtration pressure of blood in experimental hypotension.
    Pardy BJ; Dudley HA
    Br J Surg; 1975 Sep; 62(9):713-5. PubMed ID: 240477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of ACD blood titrated with THAM in extracorporeal circulation.
    MALM JR; SULLIVAN SF; PATERSON RW; BOWMAN FO; NAHAS GG
    Trans Am Soc Artif Intern Organs; 1963; 9():216-9. PubMed ID: 13932590
    [No Abstract]   [Full Text] [Related]  

  • 17. Tris buffer (THAM). An appraisal of its physiologic effects and clinical usefulness.
    Bleich HL; Schwartz WB
    N Engl J Med; 1966 Apr; 274(14):782-7. PubMed ID: 17926886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citrate-tris(hydroxymethyl)aminomethane-mediated release of outer membrane sections from the cell envelope of a deep-rough (heptose-deficient lipopolysaccharide) strain of Escherichia coli O8.
    Irvin RT; MacAlister TJ; Chan R; Costerton JW
    J Bacteriol; 1981 Mar; 145(3):1386-96. PubMed ID: 7009584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ACD blood prime on plasma calcium and magnesium.
    Killen DA; Grogan EL; Gower RE; Collins IS; Collins HA
    Ann Thorac Surg; 1972 Apr; 13(4):371-80. PubMed ID: 5019862
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in coagulation, fibrinolysis and platelet functions during extracorporeal circulation].
    Kaizu K; Uriu K; Ikeda M
    Nihon Rinsho; 2004 May; 62 Suppl 5():46-9. PubMed ID: 15197886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.